GANX
Gain Therapeutics, Inc.
$1.91
-0.08 (-4.02%)
At close · Jul 2
Market Cap
$81.47M
Shares
42,654,038
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-29 | — | |
| 8-K | 2026-06-25 | 2026-06-24 | |
| 8-K | 2026-05-26 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-05-11 | — | |
| DEF 14A | 2026-04-28 | 2026-06-24 | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-03-26 | — | |
| 8-K | 2026-03-18 | — | |
| 8-K | 2026-02-03 | — | |
| 8-K | 2025-12-18 | — | |
| 8-K | 2025-11-28 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-10-14 | — | |
| 8-K | 2025-10-09 | 2025-10-06 | |
| 8-K | 2025-10-06 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-07-17 | 2025-07-15 | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-06-24 | — | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-06-24 | |
| 8-K | 2025-04-10 | — | |
| 10-K | 2025-03-27 | 2024-12-31 | |
| 8-K | 2025-03-27 | — | |
| 8-K | 2025-02-06 | — | |
| 8-K | 2025-01-15 | 2025-01-08 | |
| 8-K | 2025-01-07 | 2025-01-06 | |
| 8-K | 2024-12-23 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-14 | — | |
| 8-K | 2024-10-21 | — | |
| 8-K | 2024-10-08 | 2024-10-07 | |
| 8-K | 2024-09-06 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-07-12 | 2024-07-11 | |
| 8-K | 2024-07-09 | — | |
| 8-K | 2024-06-28 | 2024-06-25 | |
| 8-K | 2024-06-25 | 2024-06-24 | |
| 8-K | 2024-06-14 | 2024-06-13 | |
| 8-K | 2024-05-14 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | 2024-06-24 | |
| 8-K | 2024-04-08 | 2024-04-05 | |
| 8-K | 2024-03-26 | — | |
| 10-K | 2024-03-26 | 2023-12-31 |
Showing 1–50 of 89 filings